Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chunmei Cui & Hong Lu. (2018) Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis. Clinical Interventions in Aging 13, pages 51-62.
Read now
Read now
Vibhuti Agrahari, Vivek Agrahari, Abhirup Mandal, Dhananjay Pal & Ashim K. Mitra. (2017) How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches. Expert Opinion on Drug Delivery 14:10, pages 1145-1162.
Read now
Read now
Articles from other publishers (21)
Chuanling Deng, Mingxuan Li, Yang Liu, Chi Yan, Zouyan He, Zhen-Yu Chen & Hanyue Zhu. (2023) Cholesterol Oxidation Products: Potential Adverse Effect and Prevention of Their Production in Foods. Journal of Agricultural and Food Chemistry 71:48, pages 18645-18659.
Crossref
Crossref
Sihui Hu, Yuxi Chen, Dongchun Xie, Kan Xu, Yunzhao Fu, Wei Chi, Haiying Liu & Junjiu Huang. (2023)
Nme
2
Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset
. Clinical and Translational Medicine 13:8.
Crossref
Crossref
Miriam Bobadilla, Ana Pariente, Ana I. Oca, Rafael Peláez, Álvaro Pérez-Sala & Ignacio M. Larráyoz. (2022) Biomarkers as Predictive Factors of Anti-VEGF Response. Biomedicines 10:5, pages 1003.
Crossref
Crossref
Francesca Amoroso, Eric H Souied, Salomon Yves Cohen, Alexandre Pedinielli, Polina Astroz, Rocio Blanco Garavito, Vittorio Capuano, Giuseppe Querques & Alexandra Miere. (2020) OCTA-guided navigated laser therapy for advanced macula neovascularization secondary to age related macular degeneration. European Journal of Ophthalmology 31:6, pages 3182-3189.
Crossref
Crossref
Paisan Ruamviboonsuk, Peranut Chotcomwonse, Variya Nganthavee, Warissara Pattanapongpaiboon & Kornwipa Hemarat. 2020. Choroidal Neovascularization. Choroidal Neovascularization
259
281
.
Jo Ann Buczek-Thomas, Celeste B. Rich & Matthew A. Nugent. (2019) Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions. International Journal of Molecular Sciences 20:20, pages 5065.
Crossref
Crossref
Vibhuti Agrahari, Sulabh P. Patel, Nikhil Dhall, Zach Aulgur, Siddhant Thukral, Xiaoyan Yang, Ryan Conley & Ashim K. Mitra. (2017) Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases. Drug Delivery and Translational Research 8:2, pages 422-435.
Crossref
Crossref
Jiaxian GuoXueting LuoJian LiangMeichun XiaoXiaodong Sun. (2017) Antiangiogenic Effects of Doxazosin on Experimental Choroidal Neovascularization in Mice. Journal of Ocular Pharmacology and Therapeutics 33:1, pages 50-56.
Crossref
Crossref
Malgosia M. PakulskaShane MierschMolly S. Shoichet. (2016) Designer protein delivery: From natural to engineered affinity-controlled release systems. Science 351:6279.
Crossref
Crossref
Katja Hatz, Ulrike Schneider, P. Bernhard Henrich, Beatrice Braun, Stefan Sacu & Christian Prünte. (2015) Ranibizumab plus Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: 12 Months of Retreatment and Vision Outcomes from a Randomized Study. Ophthalmologica 233:2, pages 66-73.
Crossref
Crossref
Carlos Riveros, Renato Vimieiro, Elizabeth G. Holliday, Christopher Oldmeadow, Jie Jin Wang, Paul Mitchell, John Attia, Rodney J. Scott & Pablo A. Moscato. 2015. Epistasis. Epistasis
217
255
.
Wilfred Ngwa, G Mike Makrigiorgos & Ross I Berbeco. (2012) Gold nanoparticle enhancement of stereotactic radiosurgery for neovascular age-related macular degeneration. Physics in Medicine and Biology 57:20, pages 6371-6380.
Crossref
Crossref
Christina Flaxel, Mitchell B Schain, Sara C Hamon & Peter J Francis. (2012) PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB (LUCENTIS) AND BROMFENAC (XIBROM) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina 32:3, pages 417-423.
Crossref
Crossref
Ignacio R. Rodriguez. 2012. Studies on Retinal and Choroidal Disorders. Studies on Retinal and Choroidal Disorders
321
335
.
Friedemann Kiefer & Arndt F. Siekmann. (2011) The role of chemokines and their receptors in angiogenesis. Cellular and Molecular Life Sciences 68:17, pages 2811-2830.
Crossref
Crossref
Juan Liu, Purushottam Jha, Valeriy V. Lyzogubov, Ruslana G. Tytarenko, Nalini S. Bora & Puran S. Bora. (2011) Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization. Journal of Biological Chemistry 286:23, pages 20991-21001.
Crossref
Crossref
J H Sweigard, S M Cashman & R Kumar-Singh. (2011) Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration. Gene Therapy 18:6, pages 613-621.
Crossref
Crossref
Robin J. Goody, Wenzheng Hu, Afshin Shafiee, Michael Struharik, Stephen Bartels, Francisco J. López & Matthew S. Lawrence. (2011) Optimization of laser-induced choroidal neovascularization in African green monkeys. Experimental Eye Research 92:6, pages 464-472.
Crossref
Crossref
Gary L. Yau, Christopher S. Jackman, Philip L. Hooper & Tom G. Sheidow. (2011) Intravitreal Injection Anesthesia—Comparison of Different Topical Agents: A Prospective Randomized Controlled Trial. American Journal of Ophthalmology 151:2, pages 333-337.e2.
Crossref
Crossref
Ignacio R. Rodríguez & Ignacio M. Larrayoz. (2010) Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. Journal of Lipid Research 51:10, pages 2847-2862.
Crossref
Crossref
Dong Hyun Jo, Jin Hyoung Kim & Jeong Hun Kim. (2010) How to overcome retinal neuropathy: The fight against angiogenesisrelated blindness. Archives of Pharmacal Research 33:10, pages 1557-1565.
Crossref
Crossref